Eros International Plc (NYSE:EROS) is at least 61.65% than its current record low price of $6.65. There was a -5.7% decline on 12/06/2017 that led the price to move at $10.75. At recent session, the prices were hovering between $10.3 and $11.3. This company shares are 61.21% off its target price of $17.33 and the current market capitalization stands at $668.01M. The recent change has given its price a -18.74% deficit over SMA 50 and -37.86% deficit over its 52-week high. The stock witnessed -14.68% declines, -7.33% declines and 22.16% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found EROS’s volatility during a week at 11.04% and during a month it has been found around 5.79%.Eros International Plc (EROS) Top Holders
Institutional investors currently hold around $355 million or 67% in EROS stock. Look at its top three institutional owners. Capital Research Global Investors owns $64.38 million in Eros International Plc, which represents roughly 9.64% of the company’s market cap and approximately 18.13% of the institutional ownership. Similar statistics are true for the second largest owner, Paradice Investment Management Llc, which owns 4,682,438 shares of the stock are valued at $53.38 million. The third largest holder is Gilder Gagnon Howe & Co Llc, which currently holds $47.07 million worth of this stock and that ownership represents nearly 7.05% of its market capitalization.
At the end of 09/30/2017 reporting period, 30 institutional holders increased their position in Eros International Plc (NYSE:EROS) by some 5,790,397 shares, 38 decreased positions by 1,007,095 and 11 held positions by 24,366,977. That puts total institutional holdings at 31,164,469 shares, according to SEC filings. The stock grabbed 8 new institutional investments totaling 1,856,399 shares while 11 institutional investors sold out their entire positions totaling 394,577 shares.Eros International Plc (EROS) Analyst Guide
Not many analysts have released their opinion on Eros International Plc (NYSE:EROS), with 2 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.